Stocks Health care CPIX
NASDAQ · Health careCumberland Pharmaceuticals Inc (CPIX)
Cumberland Pharmaceuticals Inc brought in $39.9M of revenue over the twelve months to June 30, 2026, down 5.2% from a year earlier. It posted a net loss of $10.9M. Operating cash flow minus capital spending left $4.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $3.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Cumberland Pharmaceuticals Inc does
Cumberland Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CPIX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $44.5M | -$2.8M | -$0.19 | $4.8M |
| 2024 | $37.9M | -$6.5M | -$0.46 | -$678.6K |
| 2023 | $39.6M | -$6.3M | -$0.44 | $5.8M |
| 2022 | $42M | -$5.6M | -$0.38 | $8.4M |
| 2021 | $36M | -$3.5M | -$0.24 | $6.2M |
| 2020 | $37.4M | -$3.3M | -$0.22 | $5.3M |
Latest SEC filings
What Cumberland Pharmaceuticals Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 11, 2026Shareholder vote results 8-K/A
- August 28, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- July 13, 2026Other event 8-K
- July 1, 2026
- June 25, 2026
- May 26, 2026Merger proxy statement DEFM14A
- May 15, 2026Form PREM14A filing PREM14A
- May 8, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about CPIX
What does Cumberland Pharmaceuticals Inc do?
Cumberland Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CPIX.
Is Cumberland Pharmaceuticals Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $10.9M on revenue of $39.9M.
How much revenue does Cumberland Pharmaceuticals Inc make?
Over the twelve months to June 30, 2026 Cumberland Pharmaceuticals Inc reported revenue of $39.9M. That is 5.2% less than a year earlier.
When did Cumberland Pharmaceuticals Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shareholder vote results from September 11, 2026.
Similar companies
Follow CPIX
Get an email when Cumberland Pharmaceuticals Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow CPIX: get an email when it filesWhere the numbers come from
Financial figures are the values Cumberland Pharmaceuticals Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.